Order Article Reprints

Angus L, Smid M, Wilting SM, Bos MK, Steeghs N, Konings IRHM, Tjan-Heijnen VCG, van Riel JMGH, van de Wouw AJ, CPCT Consortium, et al. Genomic Alterations Associated with Estrogen Receptor Pathway Activity in Metastatic Breast Cancer Have a Differential Impact on Downstream ER Signaling. Cancers. 2023; 15(17):4416. https://doi.org/10.3390/cancers15174416

Angus, Lindsay, Marcel Smid, Saskia M. Wilting, Manouk K. Bos, Neeltje Steeghs, Inge R. H. M. Konings, Vivianne C. G. Tjan-Heijnen, Johanna M. G. H. van Riel, Agnes J. van de Wouw, CPCT Consortium, and et al. 2023. "Genomic Alterations Associated with Estrogen Receptor Pathway Activity in Metastatic Breast Cancer Have a Differential Impact on Downstream ER Signaling" Cancers 15, no. 17: 4416. https://doi.org/10.3390/cancers15174416

Angus, L., Smid, M., Wilting, S. M., Bos, M. K., Steeghs, N., Konings, I. R. H. M., Tjan-Heijnen, V. C. G., van Riel, J. M. G. H., van de Wouw, A. J., CPCT Consortium, Cuppen, E., Lolkema, M. P., Jager, A., Sleijfer, S., & Martens, J. W. M. (2023). Genomic Alterations Associated with Estrogen Receptor Pathway Activity in Metastatic Breast Cancer Have a Differential Impact on Downstream ER Signaling. Cancers, 15(17), 4416. https://doi.org/10.3390/cancers15174416